Status:
UNKNOWN
Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver
Lead Sponsor:
Central Texas Veterans Health Care System
Conditions:
Hepatocellular Carcinoma
Hepatoma
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The diagnostic accuracy of EUS for detection of the liver tumors (primary and metastatic) remains unknown. To compare the accuracy of the EUS and CT scan for detection of the primary and metastatic ca...
Detailed Description
The incidence of hepatocellular carcinoma is increasing in US. The reason for this increase has been attributed to the emergence of hepatitis C. Studies suggest that patients with hepatitis C are at h...
Eligibility Criteria
Inclusion
- Patients with newly diagnosed colon, pancreatic, esophageal, lung, gastric cancer and patient with hepatitis C or B with elevated levels of alpha-fetoprotein or radiological findings suggestive of mass in the liver.
Exclusion
- Advanced heart or lung disease that precludes conscious sedation
- Liver failure
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00290316
Start Date
July 1 2004
End Date
January 1 2006
Last Update
June 7 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Texas Veterans health Care System
Temple, Texas, United States, 76504